Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
Canadian Cardiovascular Congress 2007
Putting ACE Inhibitors and ARBs into Context: Data to Confirm the Relative Importance of RAS
Quebec City, Quebec / October 20-24, 2007
Quebec City - Two major questions about the best route to vascular risk prevention will be answered within the next six months. One study will finally directly compare an angiotensin receptor blocker (ARB), an ACE inhibitor, and the...
Canadian Cardiovascular Congress 2007
Closing the Care Gap Between Guidelines and Practice
Quebec City, Quebec / October 20-24, 2007
Quebec City - Aggressive LDL-C lowering has been widely accepted by Canadian lipid experts as the most effective strategy by far to lower cardiovascular (CV) risk in high-risk patients, and the earlier the LDL-C lowering begins, the greater...
Canadian Cardiovascular Congress 2007
Targeting Postprandial Glucose for Optimal Diabetes Management
Quebec City, Quebec / October 20-24, 2007
Quebec City - Postprandial glucose (PPG) is now considered as important to the optimal management of type 2 diabetes as control of fasting glucose and HbA1c levels. Many studies in patients with and without diabetes demonstrate a strong...
Canadian Cardiovascular Congress 2007
Managing Obesity as a Cardiovascular Risk Factor: Specific Goals and New Data
Quebec City, Quebec / October 20-24, 2007
Quebec City - Obesity, which is a growing epidemic in Canada, poses an array of health threats, the most serious of which is an increased risk of cardiovascular (CV) events. A major study evaluating the effect of a pharmacologic obesity...
Canadian Cardiovascular Congress 2007
Measuring the Value of Biomarkers in Heart Failure Diagnosis and Management
Quebec City, Quebec / October 20-24, 2007
Quebec City - Canadian Cardiovascular Society guidelines indicate that B-type or brain natriuretic peptide (BNP) and its amino-terminal fragment NT-proBNP are a valuable adjunct to clinical evaluation in the diagnosis of heart failure (HF)...
Transcatheter Cardiovascular Therapeutics 2007
Contrast Agents: Hemodynamics, Electrolytes and Acute Kidney Injury
Washington, DC / October 20-25, 2007
Washington, DC - High-contrast coronary computed tomographic angiography (CTA) is a breakthrough technology for evaluating cardiac patients noninvasively. The ever-expanding volume of CTA procedures ranges in the millions, corresponding...
Canadian Cardiovascular Congress 2007
Measuring the Value of Biomarkers in Heart Failure Diagnosis and Management
Quebec City, Quebec / October 20-24, 2007
Quebec City - Canadian Cardiovascular Society (CCS) guidelines indicate that B-type or brain natriuretic peptide (BNP) and the amino-terminal fragment NT-proBNP are a valuable adjunct to clinical evaluation in the diagnosis of heart failure...
PRIORITY PRESS - 31st Annual Congress of the European Society of Cardiology
Important Update on Stroke Prevention in Patients with Atrial Fibrillation
Barcelona, Spain / August 29-September 2, 2009
Barcelona - Important new information has been generated about optimal strategies to prevent stroke in patients with atrial fibrillation. The most significant data come from a large multinational trial that associated an oral direct...
XXIst Congress of the International Society on Thrombosis and Haemostasis
Hemostatic Control in the Challenging Surgery and Trauma Patient
Geneva, Switzerland / July 6-12, 2007
Editorial Overview Keyvan Karkouti, MD, FRCPC Staff Anesthesiologist UHN-Toronto General Hospital Associate Professor of Anesthesia University of Toronto Toronto, Ontario